Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026

Bioventus (Nasdaq: BVS) will report fourth-quarter fiscal 2025 results before the market opens on March 5, 2026.

Rhea-AI Summary

Bioventus (Nasdaq: BVS) will report fourth-quarter fiscal 2025 results before the market opens on March 5, 2026.

Management will host a conference call at 8:30 a.m. Eastern Time that day. According to Bioventus, investors can dial 1-833-636-0497 or join a live webcast and view materials at the company’s Investor Relations site. The webcast will be archived and available for replay through March 4, 2027.

Argus Feb 25 session

+0.34% close to close Open Argus

Details

News Market Reaction – BVS

On Feb 25, the first trading day after this news, BVS closed 0.34% above the previous close.

Data tracked by StockTitan Argus for the Feb 25 session.

Market Context

This announcement schedules Bioventus’s Q4 fiscal 2025 results for release on March 5, 2026 and prov...

Analysis

This announcement schedules Bioventus’s Q4 fiscal 2025 results for release on March 5, 2026 and provides access details for the 8:30 a.m. ET call and webcast, which will remain archived until March 4, 2027. In recent quarters, the company reported improving profitability and reaffirmed guidance, which previously coincided with a 15.09% move after Q3 results. Investors may focus on upcoming revenue trends, margins, and guidance updates once the full Q4 data becomes available.

Key Figures

Earnings release date: March 5, 2026 Conference call time: 8:30 a.m. ET Webcast replay end: March 4, 2027 +1 more

Earnings release date

March 5, 2026

Q4 fiscal 2025 financial results release before market open

Conference call time

8:30 a.m. ET

Management earnings call and business update on release day

Webcast replay end

March 4, 2027

Investor Relations website archive availability

Conference dial-in

1-833-636-0497

Access number for Bioventus Inc. earnings conference call

Historical Context

5 past events · Latest: Jan 06

5 events

1. Jan 06

   Conference presentation

   24h Move

   +1.1%

   Announced J.P. Morgan Healthcare Conference presentation and webcast details.

2. Nov 25

   Conference presentation

   24h Move

   +5.1%

   Piper Sandler Healthcare Conference presentation and webcast availability.

3. Nov 04

   Quarterly earnings

   24h Move

   +15.1%

   Reported Q3 2025 results with improved EPS and reaffirmed guidance.

4. Oct 28

   Earnings date notice

   24h Move

   +3.4%

   Set date and access details for Q3 2025 earnings call.

5. Sep 03

   Conference participation

   24h Move

   -2.5%

   Announced participation in Morgan Stanley Global Healthcare Conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2025 before the market opens on Thursday, March 5, 2026. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 4, 2027.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bioventus (BVS) report Q4 fiscal 2025 results and what is the timing?

Bioventus will report Q4 fiscal 2025 results before market open on March 5, 2026. According to Bioventus, management will discuss results and provide a business update during a morning conference call at 8:30 a.m. ET.

How can investors join the Bioventus (BVS) conference call on March 5, 2026?

Investors can join by dialing 1-833-636-0497 and referring to the Bioventus Inc. Conference Call. According to Bioventus, a live webcast and accompanying materials will also be available on the company’s Investor Relations website.

Will Bioventus (BVS) provide a webcast and replay for the March 5, 2026 call?

Yes. According to Bioventus, the conference call will be webcast live and accompanying materials posted on the Investor Relations site. The company says the webcast will be archived and available for replay until March 4, 2027.

What topics will Bioventus (BVS) management cover on the March 5, 2026 call?

Management will discuss fourth-quarter fiscal 2025 financial results and provide a business update. According to Bioventus, the call is intended to review results and offer commentary on operations and outlook.

Where can I find the Bioventus (BVS) call materials and replay after March 5, 2026?

Call materials and the live webcast will be posted on the company’s Investor Relations site at https://ir.bioventus.com/. According to Bioventus, the replay will remain available through March 4, 2027.